Search – Page 158 – Indianapolis Business Journal

Home » Search

Articles

Drugmakers call off animal-health deal, possible asset sale

March 22, 2011

Drugmakers Merck & Co. and Sanofi-Aventis SA have abandoned plans to combine their animal-health businesses after wrestling with regulators for a year over potential divestitures.
Indianapolis-based Eli Lilly and Co. was among a list of possible suitors for about $1 billion in assets the two companies considered selling.

Marcadia Biotech principals ponder next course

March 22, 2011

Marcadia execs French, Hawryluk reflect on massive growth of Carmel firm after sale to Roche.

Rolls-Royce gives downtown office market a bounce

March 21, 2011

The decision by Rolls-Royce Corp. to occupy Eli Lilly and Co.’s Faris office campus downtown headed off what could have been a big spike in the central business district Class A office vacancy rate.

Regulators delay approval of Lilly’s Alzheimer’s screen

March 18, 2011

The Food and Drug Administration said Lilly needs to create a training program to ensure brain scans are interpreted properly.

Foundation defends risky, stock-heavy strategy

March 17, 2011

The Health Foundation of Greater Indianapolis is an aggressive supporter of charities that serve people with HIV and AIDS, but that aggression—in the form of a risky investment strategy and big payouts—almost led to its demise.

EDITORIAL: Democrats test public patience

March 17, 2011

The stalemate that sent Democrats across state lines more than four weeks ago started as a principled stand against a Republican overreach. But it’s the Democrats who will be remembered for overreaching.

Research jobs could flow from Purdue quad

March 17, 2011

Purdue University officials and others connected with the life sciences in Indiana say the planned $164 million Life and Health Sciences Quadrangle at the West Lafayette campus will mean high-paying jobs, retention of highly skilled scientists, and researchers who might well have left the state for either coast.

Trade agency to probe Lilly’s infringement claim

March 17, 2011

Eli Lilly and Co.’s patent-infringement claim over Hospira Inc.’s generic version of the cancer treatment Gemzar will be investigated by a U.S. trade agency with the power to block imports of the copycat drug.

INSIDE DISH: Cafe bolsters base of Turkish food fans

March 17, 2011

Ascending from server to owner of Bosphorus Istanbul Cafe, Orhan Demirtas has leveraged a relationship with Eli Lilly and Co. to diversify revenue, and solidified his base by opening a new breakfast cafe and hookah bar.

Gay marriage ban amendment worries Lilly, Cummins

March 16, 2011

Two of Indiana's most-prominent companies told a state Senate committee they feared their ability to recruit top employees could be hurt by a proposed constitutional amendment that would ban gay marriage and civil unions.

CARLSON: ‘Nerdy’ Daniels needs to turn laughs into votes

March 16, 2011

When someone as staid as Indiana Gov. Mitch Daniels turns out to have a sense of humor about himself, it may be time to take him seriously.

Lechleiter: After the deluge, we’ll be fine

March 15, 2011

Eli Lilly and Co. CEO John Lechleiter visited Japan last week—three days before the massive earthquake—to deliver his tried-and-true message: Drug companies need to reinvent invention, governments needs to support innovation, and Lilly will be just fine after it has sustained the damage of the next three years.

Company news

March 15, 2011

Republicans in the state Legislature are advancing a budget that would carve $7 million a year from the Indiana Medicaid plan by creating a list of preferred mental health drugs based at least partly on rebates negotiated with drug manufacturers, according to the Associated Press. Indiana is one of only nine states that does not have such a list. But groups representing doctors and patients say the money-saving could be eaten up if patients suffering from mental illnesses are unable to get the drugs they need, possibly leading to expensive hospital stays or even run-ins with police. Medicaid enrolls more than 1 million low-income Hoosiers in such programs as Hoosier Healthwise for children and pregnant woman, the Healthy Indiana Plan for uninsured, and Care Select for the disabled. The provision in the budget bill would require doctors to seek prior authorization from Medicaid to prescribe drugs not on the authorized list. However, psychiatrists would not need prior authorizations.

Elanco, the animal health division of Eli Lilly and Co., has agreed to acquire Jannsen Animal Health, a subsidiary of New Jersey-based Johnson & Johnson, pending regulatory approval. Financial terms of the deal were not disclosed. But Elanco, based in Greenfield, would acquire about 50 animal health products that Janssen sells in Europe, mostly focused on pigs, poultry and pets. Elanco also would bring on an unspecified number of Janssen’s employees. Elanco currently employs 2,300 people in more than 40 countries. Lilly has been trying to grow its animal health business through acquisitions in order to build up revenue expected to be lost late this year when its best-selling human drug Zyprexa faces competition from cheaper generic copies. They will sap most of Zyprexa’s $5 billion a year in sales. Last year, Elanco pulled in revenue of nearly $1.4 billion, up 15 percent from the previous year. Elanco’s drugs are mainly for pigs, poultry, cows and pets.

Rolls-Royce moving 2,500 workers downtown

March 15, 2011

The British-based company will move the office workers later this year to a downtown Indianapolis office building on South Meridian Street formerly occupied by Eli Lilly and Co.

Lilly agrees to buy European animal health company

March 14, 2011

Elanco, the animal health division of Eli Lilly and Co., has agreed to acquire Jannsen Animal Health, a subsidiary of New Jersey-based Johnson & Johnson, pending regulatory approval. Financial terms of the deal were not disclosed.

Indianapolis’ Christ Church Cathedral supports rebuilding of cathedral in Haiti

March 10, 2011

The local church is joining Trinity Wall Street Church in New York in donating to reconstruction of the building destroyed in the January 2010 earthquake.

Lilly confident of FDA approval for Amyvid, Lechleiter says

March 9, 2011

Eli Lilly and Co. CEO John Lechleiter said he’s confident of gaining U.S. regulatory approval for a drug to help identify plaque in the brain associated with Alzheimer’s disease.

Company news

March 8, 2011

Eli Lilly and Co.’s chief of neuroscience research, who announced his departure last month, was actually poached from Lilly by New Jersey-based Johnson & Johnson, according to the Wall Street Journal. Dr. David Bredt, who had been Indianapolis-based Lilly’s vice president of neuroscience discovery research and clinical investigation, started at Johnson on Feb. 28. Bredt came to Lilly in 2004 from the University of California at San Francisco Medical School, leading the company’s crucial Alzheimer’s research. He is the second top-level executive Lilly has lost this year. In January, John Johnson, the company's chief of oncology, resigned to become CEO at New Jersey-based Savient Pharmaceuticals Inc.

A life sciences networking group that got started in Philadelphia is now starting a chapter in Indianapolis. Pharma Thursday tries to connect professionals in the drug, device, diagnostic and biotech industries—regardless of which company they work for—as well as academic researchers. The first Indianapolis event takes place April 21 at 6 p.m. at Rock Bottom Brewery downtown. Pharma Thursdays started in November 2008 and reached 1,000 participants in Philadelphia in September 2010. The group also has chapters in Princeton, N.J., New York City and South Florida.

Lafayette-based Subaru of Indiana Automotive is the latest Hoosier employer to add an on-site health clinic, breaking ground on the facility last week. Managed by Florida-based WeCare TLC, the center will provide care to Subaru workers, retirees and dependents, once it opens this summer. Tom Easterday, Subaru of Indiana’s executive vice president, said the on-site clinic should help reduce employees’ health care costs and give them added care to improve their overall health.

In the latest acquisition of physicians by a local hospital system, Franciscan St. Francis Health has acquired Indy Southside Surgical, adding five general surgeons to its St. Francis Medical Group stable of physicians. Indy Southside Surgical had been affiliated with the St. Francis hospital system since 1989. The practice, which has offices in Indianapolis and Mooresville, includes Dr. David Mandelbaum, Dr. Jonathan Mandelbaum, Dr. Donald King, Dr. Matthew Libke and Dr. Mark Edwards. All earned their medical degrees at the Indiana University School of Medicine.

Lilly suffers another bruise from Novo

March 8, 2011

The failure of its drug Bydureon to match the performance of Novo’s Victoza trims but doesn’t kill sales prospects for the highly touted diabetes drug.

Others states’ fights bring focus to Gov. Daniels

March 8, 2011

Gov. Mitch Daniels has spent years talking about issues that typically make voters' eyes glaze over: Cutting spending. Balancing budgets. Shrinking government. The priorities haven't changed much in Daniels' six years as governor. But suddenly voters are paying attention.

« Previous 1 … 156 157 158 159 160 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Drugmakers call off animal-health deal, possible asset sale

Marcadia Biotech principals ponder next course

Rolls-Royce gives downtown office market a bounce

Regulators delay approval of Lilly’s Alzheimer’s screen

Foundation defends risky, stock-heavy strategy

EDITORIAL: Democrats test public patience

Research jobs could flow from Purdue quad

Trade agency to probe Lilly’s infringement claim

INSIDE DISH: Cafe bolsters base of Turkish food fans

Gay marriage ban amendment worries Lilly, Cummins

CARLSON: ‘Nerdy’ Daniels needs to turn laughs into votes

Lechleiter: After the deluge, we’ll be fine

Company news

Rolls-Royce moving 2,500 workers downtown

Lilly agrees to buy European animal health company

Indianapolis’ Christ Church Cathedral supports rebuilding of cathedral in Haiti

Lilly confident of FDA approval for Amyvid, Lechleiter says

Company news

Lilly suffers another bruise from Novo

Others states’ fights bring focus to Gov. Daniels